Cargando…
Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study
BACKGROUND: Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We examined if there were differences in endothelial function, insulin stimulated endothe...
Autores principales: | Falskov, Britt, Hermann, Thomas Steffen, Raunsø, Jakob, Christiansen, Buris, Rask-Madsen, Christian, Major-Pedersen, Atheline, Køber, Lars, Torp-Pedersen, Christian, Dominguez, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212926/ https://www.ncbi.nlm.nih.gov/pubmed/21999413 http://dx.doi.org/10.1186/1475-2840-10-91 |
Ejemplares similares
-
Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study
por: Kveiborg, Britt, et al.
Publicado: (2010) -
The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive
por: Falskov, Britt, et al.
Publicado: (2011) -
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007) -
Ingestion of Broccoli Sprouts Does Not Improve Endothelial Function in Humans with Hypertension
por: Christiansen, Buris, et al.
Publicado: (2010) -
Long‐Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study
por: Schwartz, Brian, et al.
Publicado: (2021)